01.24.24
RoC Skincare, the French dermatological brand, will be acquired by Bridgepoint Capital. Terms of the acquisition were not disclosed. The deal is expected to be completed next month. Gryphon Investors, RoC’s biggest investor, will sell its majority stake to Bridgeport at part of the acquisition.
The deal will go through Bridgepoint Europe VII, Bridgepoint’s fund centered on investing in mid-market growth businesses.
“The dermocosmetic facial skincare market in the US and Europe is set to continue to grow ahead of the broader skin care space, a trend mirrored in products for aging skin,” Bridgepoint said in a statement.
Gryphon Investors, San Francisco, acquired RoC Skincare from Johnson & Johnson in 2019. J&J spun-off its consumer products business in 2022. Kenvue owns such well-known brands as Johnson's, Aveeno and Listerine.
RoC Skincare Collaborates with Dermatologists for Restorative Skin Barrier Collection
Gryphon Investors Acquires Revison Goodier
The deal will go through Bridgepoint Europe VII, Bridgepoint’s fund centered on investing in mid-market growth businesses.
“The dermocosmetic facial skincare market in the US and Europe is set to continue to grow ahead of the broader skin care space, a trend mirrored in products for aging skin,” Bridgepoint said in a statement.
Gryphon Investors, San Francisco, acquired RoC Skincare from Johnson & Johnson in 2019. J&J spun-off its consumer products business in 2022. Kenvue owns such well-known brands as Johnson's, Aveeno and Listerine.
Related Content:
RoC Skincare Collaborates with Dermatologists for Restorative Skin Barrier Collection
Gryphon Investors Acquires Revison Goodier